A 41-year-old asthmatic woman presented to our emergency department ex
hibiting symptoms of lethargy, respiratory distress, and tachycardia.
Baseline laboratory investigation revealed a significantly elevated th
eophylline level as well as marked hypercalcemia (calcium = 16.0 mg/dL
). Serum calcium normalized after theophylline was discontinued. The u
nusual level of hypercalcemia secondary to theophylline toxicity may h
ave been related to the action of beta agonists (used in conjunction w
ith theophylline to treat bronchospasm), dehydration, or concomitant m
ild hyperthyroidism. Suppressed parathyroid hormone (PTH) and 1-25 dih
ydroxy vitamin D levels measured in our patient suggest a mode of acti
on for theophylline-induced hypercalcemia that is completely independe
nt of PTH action.